Excess tuberculosis risk during and following incarceration in Paraguay: a retrospective cohort study.

Epidemiology Paraguay Prisons Transmission Tuberculosis

Journal

Lancet regional health. Americas
ISSN: 2667-193X
Titre abrégé: Lancet Reg Health Am
Pays: England
ID NLM: 9918232503006676

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 28 06 2023
revised: 22 12 2023
accepted: 26 12 2023
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: epublish

Résumé

The increased risk of tuberculosis (TB) among people deprived of liberty (PDL) is due to individual and institution-level factors. We followed a cohort of PDL from 5 prisons in Paraguay to describe the risk of TB during incarceration and after they were released. We linked a 2013 national census of prisons with TB records from the TB Program from 2010 to 2021 to identify TB notifications among incarcerated and formerly incarcerated individuals. We used multivariable Cox regression models to quantify the risk of TB during and following incarceration and to identify risk factors associated with TB. Among 2996 individuals incarcerated, 451 (15.1%) were diagnosed with TB. Of these, 262 (58.1%) cases occurred during incarceration and 189 (41.9%) occurred in the community after release. In prison, the hazard ratio of developing TB was 1.97 (95% CI: 1.52-2.61) after six months of incarceration and increased to 2.78 (95% CI: 1.82-4.24) after 36 months compared with the first six months. The overall TB notification rate was 2940 per 100,000 person-years. This rate increased with the duration of incarceration from 1335 per 100,000 person-years in the first year to 8455 per 100,000 person-years after 8 years. Among former prisoners, the rate of TB decreased from 1717 in the first year after release to 593 per 100 000 person-years after 8 years of follow up. Our study shows the alarming risk of TB associated with prison environments in Paraguay, and how this risk persists for years following incarceration. Effective TB control measures to protect the health of people during and following incarceration are urgently needed. Paraguay National Commission of Science and Technology grant CONACYT PIN 15-705 (GS, GES, SA).

Sections du résumé

Background UNASSIGNED
The increased risk of tuberculosis (TB) among people deprived of liberty (PDL) is due to individual and institution-level factors. We followed a cohort of PDL from 5 prisons in Paraguay to describe the risk of TB during incarceration and after they were released.
Methods UNASSIGNED
We linked a 2013 national census of prisons with TB records from the TB Program from 2010 to 2021 to identify TB notifications among incarcerated and formerly incarcerated individuals. We used multivariable Cox regression models to quantify the risk of TB during and following incarceration and to identify risk factors associated with TB.
Findings UNASSIGNED
Among 2996 individuals incarcerated, 451 (15.1%) were diagnosed with TB. Of these, 262 (58.1%) cases occurred during incarceration and 189 (41.9%) occurred in the community after release. In prison, the hazard ratio of developing TB was 1.97 (95% CI: 1.52-2.61) after six months of incarceration and increased to 2.78 (95% CI: 1.82-4.24) after 36 months compared with the first six months. The overall TB notification rate was 2940 per 100,000 person-years. This rate increased with the duration of incarceration from 1335 per 100,000 person-years in the first year to 8455 per 100,000 person-years after 8 years. Among former prisoners, the rate of TB decreased from 1717 in the first year after release to 593 per 100 000 person-years after 8 years of follow up.
Interpretation UNASSIGNED
Our study shows the alarming risk of TB associated with prison environments in Paraguay, and how this risk persists for years following incarceration. Effective TB control measures to protect the health of people during and following incarceration are urgently needed.
Funding UNASSIGNED
Paraguay National Commission of Science and Technology grant CONACYT PIN 15-705 (GS, GES, SA).

Identifiants

pubmed: 38500958
doi: 10.1016/j.lana.2023.100668
pii: S2667-193X(23)00242-9
pmc: PMC10945421
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100668

Informations de copyright

© 2023 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

All authors report no potential conflicts.

Auteurs

Guillermo Sequera (G)

Cátedra de Salud Pública, Universidad Nacional de Asunción (UNA), Paraguay.
ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Gladys Estigarribia-Sanabria (G)

Instituto Regional de Investigación en Salud, Universidad Nacional de Caaguazú- (UNCA), Coronel Oviedo, Paraguay.
School of Medicine, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.

Sarita Aguirre (S)

Programa Nacional de Control de la Tuberculosis, Asunción, Paraguay.

Claudia Piñanez (C)

Departamento de Sanidad Penitenciaria, Ministerio de Justicia, Paraguay.

Leonardo Martinez (L)

Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA.

Rafael Lopez-Olarte (R)

Former Regional Tuberculosis Adviser, Pan American Health Organization, Washington, DC, USA.

Jason R Andrews (JR)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Katharine S Walter (KS)

Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.

Julio Croda (J)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
School of Medicine, Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.
Oswaldo Cruz Foundation Mato Grosso do Sul, Mato Grosso do Sul, Brazil.

Alberto L Garcia-Basteiro (AL)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saude de Manhiça (CISM), Maputo, Mozambique.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.

Classifications MeSH